Home DNA Damage/DNA Repair Antineoplastic and Immunosuppressive Antibiotics inhibitor - Topoisomerase inhibitor - ADC Cytotoxin - COVID-19 inhibitor - DNA/RNA Synthesis inhibitor - Apoptosis related activator Daunorubicin (RP 13057) HCl

Daunorubicin (RP 13057) HCl

Catalog No.S3035 Synonyms: Daunomycin HCl, Rubidomycin HCl

For research use only.

Daunorubicin HCl (Daunomycin, RP 13057, Rubidomycin) inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay. Daunorubicin is a topoisomerase II inhibitor that induces apoptosis.

Daunorubicin (RP 13057) HCl Chemical Structure

CAS No. 23541-50-6

Selleck's Daunorubicin (RP 13057) HCl has been cited by 53 publications

Purity & Quality Control

Choose Selective Antineoplastic and Immunosuppressive Antibiotics Inhibitors

Related Compound Libraries

Biological Activity

Description Daunorubicin HCl (Daunomycin, RP 13057, Rubidomycin) inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay. Daunorubicin is a topoisomerase II inhibitor that induces apoptosis.
Targets
DNA synthesis [1]
(Cell-free assay)
20 nM(Ki)
In vitro

At drug concentrations that reflect the peak plasma concentration after Daunorubicin administration, the primary mechanism is likely to be through interaction with topoisomerase II, which may be a primary triggering event for growth arrest and/or cell killing through a signalling pathway leading to apoptosis, at least in leukemic cells and thymocytes. The quinone structure permits daunorubicin to act as electron acceptors in reactions mediated by oxoreductive enzymes including cytochrome P450 reductase, NADH dehydrogenase, and xanthine oxidase. At Daunorubicin concentrations exceeding approximately 2–4 μM, free radical mediated toxicity and DNA cross-linking may become evident. Daunorubicin inhibits both DNA and RNA syntheses in HeLa cells over a concentration range of 0.2 through 2 μM. Daunorubicin inhibits both DNA syntheses in Ehrlich ascites tumor cells over a concentration range of 4 μM. Daunorubic triggers apoptosis at concentrations of 0.5 and 1 μM in either HL-60 or U-937 human leukemic cells. [1] Daunorubicin stimulates ceramide elevation and apoptosis in P388 and U937 cells through de novo synthesis via activation of the enzyme ceramide synthase. [2] Daunorubicin dose-dependently increases the phosphatidylserine exposure and consequent procoagulant activity of human umbilical vein endothelial cells. Daunorubicin (0.2 mM) significantly enhances the release of endothelial microparticles which are highly procoagulant in human umbilical vein endothelial cells. [3]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MDA MB 361(mammary carcinoma cell line) M1P0fGN6fG:2b4jpZ:Kh[XO|YYm= M3;IdHRp\SClb33wc5Vv\CC5YYOgeIV{fGWmIH\vdkBqdnS{YXPlcIx2dGG{IHP5eI91d3irY3n0fUBi\2GrboP0JG1FSSCPQjCzOlEpdWGvbXHyfUBk[XKlaX7vcYEh[2WubDDsbY5mMSCneIDy[ZN{cW6pIFzhZ3ohMGKndHGt[4Ft[WO2b4Pp[IF{\SluIFnDOVA:OTdibl2= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yODN7NUS5NEc,OTB|OUW0PVA9N2F-
P388 leukemia cell line MXPDfZRwfG:6aXRCpIF{e2G7 M3nEbWNwdXCxdX7kJJdieyCndnHseYF1\WRiZn;yJIN6fG:2b4jpZ4l1gSCjZ3HpcpN1KFB|OEigcIV2c2WvaXGgZ4VtdCCuaX7lMEBKSzVyPUOgcm0> NWTtc41sRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC0O|kzQTdpPkGwOFc6Ojl5PD;hQi=>
Dx5 w/PSC cell lines M3rXe2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MYHUbIUh[2:vcH;1coQhf2G|IHX2ZYx2[XSnZDDmc5IhfGinIHfyc5d1cCCrbnjpZol1cW:wIH;mJGR5PSC5L2DTR{Bk\WyuIHzpcoV{KHW|aX7nJG1VXCCjc4PhfUwhUUN3ME2xOEBvVQ>? MnHjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB4OUi0OFkoRjFyNkm4OFQ6RC:jPh?=
MES-SA uterine tumor cell lines MYnHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NH[0THBVcGViY3;tdI92dmRid3HzJIV3[Wy3YYTl[EBnd3JidHjlJIdzd3e2aDDpcohq[mm2aX;uJI9nKE2HUz3TRUB2fGW{aX7lJJR2dW:{IHPlcIwhdGmwZYOgeZNqdmdiTWTUJIF{e2G7LDDJR|UxRTBwMEKxJO69VQ>? M3jHe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFyNkm4OFQ6Lz5zME[5PFQ1QTxxYU6=
Dx5 cell lines MXjHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NUDaO41CXGinIHPvcZBwfW6mIIfhd{BmfmGudXH0[YQh\m:{IITo[UBoem:5dHigbY5pcWKrdHnvckBw\iCGeEWgZ4VtdCCuaX7ld{B2e2mwZzDNWHQh[XO|YYmsJIlkPTB;MjFOwG0> NVXqcokzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC2PVg1PDlpPkGwOlk5PDR7PD;hQi=>
human epidermoid carcinoma cell line KB-3-1 NFfUS5REgXSxdH;4bYPDqGG|c3H5 NH3N[FRKdiC4aYTyc{BkgXSxdH;4bYMh[WO2aY\peJkhf2G|IHX2ZYx2[XSnZDD1d4lv\yC2aHWgbJVu[W5iZYDp[IVzdW:rZDDjZZJkcW6xbXGgZ4VtdCCuaX7lJGtDNTNvMTygTWM2OD15IH7N NVzSPJpKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK0OFM4PjNpPkGyOFQ{PzZ|PD;hQi=>
human uterine sarcoma cell line MES-SA MmjzR5l1d3SxeHnjxsBie3OjeR?= M{LHd2lvKH[rdILvJIN6fG:2b4jpZ{Bi[3Srdnn0fUB4[XNiZY\hcJVifGWmIIXzbY5oKHSqZTDoeY1idiC3dHXybY5mKHOjcnPvcYEh[2WubDDsbY5mKE2HUz3TRUwhUUN3ME2wMlA4KM7:TR?= NVi2bVgzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK0OFM4PjNpPkGyOFQ{PzZ|PD;hQi=>
Jurkat T lymphocytes NYXubY1VS3m2b4TvfIlkyqCjc4PhfS=> MkmzR5l1d3SxeHnjbZR6KGGpYXnud5QhUnW{a3H0JHQhdHmvcHjvZ5l1\XNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNFgzPiEQvF2= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjN4Nk[wNkc,OTZ|Nk[2NFI9N2F-
human HeLa3 cell line MXXDfZRwfG:6aXRCpIF{e2G7 M{fEU2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGF|IHPlcIwhdGmwZTDifUBOXFRiYYPzZZktKEmFNUC9Nk46PiEQvF2= MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPjl2MkCzO{c,OTZ7NEKwN|c9N2F-
NCI-H69 cell line NGjJVYFRem:uaX\ldoF1cW:wIHHzd4F6 NI\TN4xCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIRzfWdic3Xud4l1cX[nIF7DTU1JPjliY3XscEBtcW6nIHL5JGFt[W2jcjDCcJVmKGG|c3H5MEBKSzVyPUCuNUDPxE1? M1v4XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5Mki2N|k{Lz5zN{K4OlM6OzxxYU6=
L1210 NIDCcHBHfW6ldHnvckBie3OjeR?= MU\Jcohq[mm2aX;uJI9nKFKQQTDzfY51cGW|aYOgbY4hdW:3c3WgUFEzOTBiY3XscJMtKEWGNUCgQUAxNjNizszNMi=> NYHyfoo2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxNEKzNVgyLz52MkOxPFE9N2F-
L1210 M2nRNmZ2dmO2aX;uJIF{e2G7 NHjJZXlKdmirYnn0bY9vKG:oIFTORUB{gW62aHXzbZMhcW5ibX;1d4UhVDF{MUCgZ4VtdHNuIFXEOVAhRSBzIN88UU4> NHHydW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi92MkOxPFEoRjR{M{G4NVww[T5?
L1210 NWTQb4h7TnWwY4Tpc44h[XO|YYm= Ml\FTY5pcWKrdHnvckBw\iCUTlGgd5lvfGinc3nzJIlvKG2xdYPlJGwyOjFyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhYzOKXYXybYRqdmViaX7jc5Jxd3KjdHnvckwhTUR3MDC9JFAvOyEQvF2u M4D0[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzR7MEWzO{c,PDlyNUO3QE9iRg>?
L1210 NUDpXYVoTnWwY4Tpc44h[XO|YYm= MonLTY5pcWKrdHnvckBw\iCGTlGgd5lvfGinc3nzJIlvKG2xdYPlJGwyOjFyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhYzOKXYTofY1q\GmwZTDpcoNwenCxcnH0bY9vNCCHREWwJF0hOC52IN88UU4> NFLkUG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi92OUC1N|coRjR7MEWzO|ww[T5?
L1210 MUXGeY5kfGmxbjDhd5NigQ>? MoHTTY5pcWKrdHnvckBw\iCdM1jdeZJq\GmwZTDpcoNwenCxcnH0bY9vKGmwdH:gdJJwdGmoZYLheIlv\yCOMUKxNEBk\WyuczygSWQ2OCB;IECuN|Mh|ryPLh?= NHHpZ289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi94N{G2OFAyLz54N{G2OFAyRC:jPh?=
L1210 MWjGeY5kfGmxbjDhd5NigQ>? M2XnVmlvcGmkaYTpc44hd2ZiW{PIYZRpgW2rZHnu[UBqdmOxcoDvdoF1cW:wIHnueI8heHKxbHnm[ZJifGmwZzDMNVIyOCClZXzsd{whTUR3MDC9JFAvPjZizszNMi=> MoeyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPjdzNkSwNUc,PjdzNkSwNVww[T5?
L1210 Mn;RSpVv[3Srb36gZZN{[Xl? NFezRWpFd3OnIILldZVqemWmIITvJIlvcGmkaYSgeIhmKFKQQTDzfY51cGW|aYOgbY4hdGW3a3XtbYEhVDF{MUCgZ4VtdHNuIFXEOVAhRSByLkOg{txONg>? MnrpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPzJ3Mkm3Okc,PzJ3Mkm3Olww[T5?
L1210 M33zfmZ2dmO2aX;uJIF{e2G7 MlfVSI9{\SC{ZYH1bZJm\CC2bzDpcohq[mm2IITo[UBFVkFic4nueIhme2m|IHnuJIxmfWunbXnhJGwyOjFyIHPlcIx{NCCHREWwJF0hOSEQvF2u M1rBT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493Nzd{NUK5O|YoRjd{NUK5O|Y9N2F-
MCF7 MULDfZRwfG:6aXPpeJkh[XO|YYm= MVi0PEBpenN? NUDCdpp6S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5{MjFOwG0v M1\TcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MUmwOFQ4Lz5zN{G5NFQ1PzxxYU6=
MDA-MB-231 NXfHdJh7S3m2b4TvfIlkcXS7IHHzd4F6 MYq0PEBpenN? MWLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkK1JO69VS5? Mo\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTdzOUC0OFcoRjF5MUmwOFQ4RC:jPh?=
HeLa M{H3NWN6fG:2b4jpZ4l1gSCjc4PhfS=> NFqxbmY1QCCqcoO= NWfndHdES3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5|MjFOwG0v NFjMTIY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{G5NFQ1Pyd-MUexPVA1PDd:L3G+
PC-3 NGj5UFdEgXSxdH;4bYNqfHliYYPzZZk> MlnkOFghcHK| NULhXHFUS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWENvMzDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC52NDFOwG0v NVL3ZXpORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUexPVA1PDdpPkG3NVkxPDR5PD;hQi=>
Yoshida sarcoma tumor cells MkfCSpVv[3Srb36gZZN{[Xl? MnTDR49v[2WwdILheIlwdiCrbnjpZol1cW6pIGuzTH1V\FJiaX7jc5Jxd3KjdHnvckBqdiC\b4PobYRiKHOjcnPvcYEhfHWvb4KgZ4VtdHNiaX6geol1em9iaX6gdoF1eyxiSVO1NEA:KDBwMEKg{txONg>? NWLaSJBVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUOyNlk5Pid-MUOyNlk5PjxxYU6=
HL60 M3\JT2Fxd3C2b4Ppd{Bie3OjeR?= NYTCUZJtUW5idnn0do8h[2:wY3XueJJifGmxbjDy[ZF2cXKnZDD0c{BqdmS3Y3WgZZBweHSxc3nzJIlvKEiONkCgZ4VtdHNuIFHDOVAhRSByLkC0JO69VS5? MlHxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTJ6N{e1PVMoRjF{OEe3OVk{RC:jPh?=
HL60R MWHBdI9xfG:|aYOgZZN{[Xl? NEHUO4dKdiC4aYTyc{Bkd26lZX70doF1cW:wIILldZVqemWmIITvJIlv\HWlZTDhdI9xfG:|aYOgbY4hUEx4MGKgZ4VtdHNuIFHDOVAhRSBzMDFOwG0v NYDvU2R{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK4O|c2QTNpPkGyPFc4PTl|PD;hQi=>
HL60 NUjLRYtnS3m2b4TvfIlkcXS7IHHzd4F6 MXTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIUFYxKGOnbHzzJIFnfGW{IES4JIhzeyCkeTD0dplx[W5iYnz1[UBmgGOudYPpc44hdWW2aH;kMEBCSzVyIE2gNE4yKM7:TT6= NWD5bVJ6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUizN|k1PTVpPkG4N|M6PDV3PD;hQi=>
HL60 NILwR3hCeG:ydH;zbZMh[XO|YYm= Ml;sTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDteYx1cWS{dXegdoV{cXO2YX70JIh2dWGwIFjMOlAh[2WubIOgZYZ1\XJiNEigbJJ{NCCDQ{WwJF0hOzhizszNMi=> M1niTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6M{O5OFU2Lz5zOEOzPVQ2PTxxYU6=
HTB-81 NEDKSndEgXSxdH;4bYNqfHliYYPzZZk> M{TjO2N6fG:2b4jpZ4l1gSC2aHH0JINifXOnZDDhJFUxLSC{ZXT1Z5Rqd25iaX6gZYJ{d3KkYX7j[UBifCB2OUCgco0hcW5iaIXtZY4heHKxc4TheIUh[2GwY3XyJGhVSi16MTDj[YxteyC3c3nu[{BOXFNiYYPzZZktKEWFNUCgQUAxNjB3ODFOwG0v NGjOSHY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUCyNFI5PSd-MUGwNlAzQDV:L3G+
B16 M1O1SWN6fG:2b4jpZ4l1gSCjc4PhfS=> NGq0SYNEgXSxdH;4bYNqfHlidHjheEBk[XW|ZXSgZUA2OCVicnXkeYN1cW:wIHnuJIFje2:{YnHuZ4Uh[XRiNEmwJI5uKGmwIFKxOkBud3W|ZTDt[Yxidm:vYTDj[YxteyC3c3nu[{BOXFNiYYPzZZktKEWFNUCgQUAxNjF4IN88UU4> M4DGRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzMEKwNlg2Lz5zMUCyNFI5PTxxYU6=
fibroblast (NHF) cells NUntboVTS3m2b4TvfIlkcXS7IHHzd4F6 Mkf4R5l1d3SxeHnjbZR6KHSqYYSgZ4F2e2WmIHGgOVAmKHKnZIXjeIlwdiCrbjDhZpNwemKjbnPlJIF1KDR7MDDucUBqdiCwb4LtZYwhcHWvYX6g[oljem:kbHHzeEApVkiIKTDj[YxteyC3c3nu[{BOXFNiYYPzZZktKEWFNUCgQUAxNjJ{IN88UU4> MonYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTFyMkCyPFUoRjFzMEKwNlg2RC:jPh?=
L1210 MnTXSpVv[3Srb36gZZN{[Xl? MlfvN{BpenN? MlLiTY5pcWKrdHnvckBw\iCGTlGgd5lvfGinc3nzJIlvKG2xdYPlJGwyOjFyIHPlcIx{KHC{ZXnuZ5Vj[XSnZDDmc5IhOyCqcoOg[o9tdG:5ZXSgZpkhYzOKXT30bJlucWSrbnWgZYRlcXSrb36gcYVie3W{ZXSgZYZ1\XJiMTDodkBjgSC|Y3nueIltdGG2aX;uJJNx\WO2cn;t[ZRzcWNiYX7hcJl{cXNuIFXEOVAhRSByLkOg{txONg>? NFzFS3Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{[zOVkoRjF5NkO1PVww[T5?
L1210 M3L4WWZ2dmO2aX;uJIF{e2G7 M{KxXVMhcHK| NV7GbYxiUW6qaXLpeIlwdiCxZjDSUmEhe3mwdHjld4l{KGmwIH3veZNmKExzMkGwJINmdGy|IIDy[Ylv[3WkYYTl[EBnd3JiMzDodpMh\m:ubH;3[YQh[nliW{PIYU12emmmaX7lJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEGgbJIh[nlic3PpcpRqdGyjdHnvckB{eGWldILvcYV1emmlIHHuZYx6e2m|LDDFSFUxKD1iMD6zJO69VS5? NEPPOlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{[zOVkoRjF5NkO1PVww[T5?
L1210 MoLSSpVv[3Srb36gZZN{[Xl? MkPQTY5pcWKrdHnvckBw\iCUTlGgd5lvfGinc3nzJIlvKG2xdYPlJGwyOjFyIHPlcIx{NCCHREWwJF0hOC5|MzFOwG0v MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek81OjNzOEKnQlQzOzF6MkyvZV4>
L1210 MXfGeY5kfGmxbjDhd5NigQ>? M2\1XmlvcGmkaYTpc44hd2ZiRF7BJJN6dnSqZYPpd{BqdiCvb4Xz[UBNOTJzMDDj[YxteyxiRVS1NEA:KDBwNk[g{txONg>? M3W4PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzR{M{G4Nkc,PDJ|MUiyQE9iRg>?
L1210 NHq4bIhHfW6ldHnvckBie3OjeR?= NW\WTJZCUW6qaXLpeIlwdiCxZjDSUmEhe3mwdHjld4l{KGmwIH3veZNmKExzMkGwJINmdGy|LDDFSFUxKD1iMD6zN{DPxE1w NYe5S4NsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxNEmwOVM3Lz52OUC1N|Y9N2F-
L1210 M1LaeGZ2dmO2aX;uJIF{e2G7 NHfyXG1KdmirYnn0bY9vKG:oIFTORUB{gW62aHXzbZMhcW5ibX;1d4UhVDF{MUCgZ4VtdHNuIFXEOVAhRSByLk[2JO69VS5? Ml3QQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPDlyNUO2K|41QTB3M{[8M4E,
L1210 M2jqfGZ2dmO2aX;uJIF{e2G7 NVTPUZpmUW6qaXLpeIlwdiCxZjDSUmEhe3mwdHjld4l{KGmwIH3veZNmKExzMkGwJINmdGy|LDDFSFUxKD1iMD6yN{DPxE1w Ml3oQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPjlyOUm5K|43QTB7OUm8M4E,
L1210 MV;GeY5kfGmxbjDhd5NigQ>? M3;Zc2lvcGmkaYTpc44hd2ZiRF7BJJN6dnSqZYPpd{BqdiCvb4Xz[UBNOTJzMDDj[YxteyxiRVS1NEA:KDBwNEig{txONg>? M4n6SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzZ7MEm5PUc,PjlyOUm5QE9iRg>?
L1210 MXzGeY5kfGmxbjDhd5NigQ>? NHr6b|ZEd22yb4Xu[EB4[XNiZY\hcJVifGWmIH\vdkB1cGViNUClJIlvcGmkaYTpc44hd2ZidHjlJIlv[2:{cH;yZZRqd25ib3[gX|NJZS1idHj5cYllcW6nIHnuJJRp\SCUTlGgLIlvcGmkaYTpc44hd2Zic4nueIhme2m|IHnuJIxmfWunbXnhJGwyOjFyIHPlcIx{MSxiRVS1NEA:KDBwM{Og{txONg>? M1;uZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzN5NkGzNlUoRjN5NkGzNlU9N2F-
L1210 M17YfWZ2dmO2aX;uJIF{e2G7 MV7Dc41xd3WwZDD3ZZMh\X[jbIXheIVlKG[xcjD0bIUhPTBnIHnubIljcXSrb36gc4YhfGinIHnuZ49zeG:{YYTpc44hd2ZiW{PIYU0hfGi7bXnkbY5mKGmwIITo[UBFVkFiKHnubIljcXSrb36gc4Yhe3mwdHjld4l{KGmwIHzleYtmdWmjIFyxNlExKGOnbHzzLUwhTUR3MDC9JFAvPjZizszNMi=> MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{PzZzM{K1K|4{PzZzM{K1QE9iRg>?
L1210 M{i1bmZ2dmO2aX;uJIF{e2G7 MljLR49v[2WwdILheIlwdiCxZjDkdpVoKG6nY3Xzd4FzgSC2bzDy[YR2[2ViYomgOVAmKHSqZTDpcoNwenCxcnH0bY9vKG:oIITybZRq[XSnZDD1dollcW6nIHnuJJRp\SCUTlGgc4Yh[WO2aY\lcJkh\3Kxd3nu[{BNOTJzMDDj[YxteyxiRVS1NEA:KDBwM{Og{txONg>? NYWzfolsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxN{C4OlgyPid-N{C4OlgyPjxxYU6=
L1210 M3jVb2Z2dmO2aX;uJIF{e2G7 NET0dnNEd26lZX70doF1cW:wIH;mJIRzfWdibnXj[ZN{[XK7IITvJJJm\HWlZTDifUA2OCVidHjlJIlv[2:{cH;yZZRqd25ib3[geJJqfGmjdHXkJJRpgW2rZHnu[UBqdiC2aHWgSG5CKG:oIHHjeIl3\Wy7IHfyc5dqdmdiTEGyNVAh[2WubIOsJGVFPTBiPTCwMlY3KM7:TT6= NYqzPWxORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxN{C4OlgyPid-N{C4OlgyPjxxYU6=
NCI60 M3HYRmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NXO3[oZpT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hVkOLNkCgZ4VtdHNuIFfJOVAhRSByLkC0OEDPxE1w M3;nNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OUS0OlEzLz5zOUm0OFYyOjxxYU6=
MDA-MB-231 MUDDfZRwfG:6aXPpeJkh[XO|YYm= Mkj2O|IhcHK| NH73b|JEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwJF0hOC5yMjFOwG0v NUfBdHlQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm5OlgzPThpPkG5PVY5OjV6PD;hQi=>
HT-29 Mmj4R5l1d3SxeHnjbZR6KGG|c3H5 MknCO|IhcHK| M324UWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhVNTJ7IHPlcIx{KGGodHXyJFczKGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxKD1iMD6wO{DPxE1w NYDHVFJyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm5OlgzPThpPkG5PVY5OjV6PD;hQi=>
A549 NWj1ZnBHS3m2b4TvfIlkcXS7IHHzd4F6 MmnOO|IhcHK| MVjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwJF0hOC5yODFOwG0v M4PSeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OU[4NlU5Lz5zOUm2PFI2QDxxYU6=
K562 Ml;aR5l1d3SxeHnjbZR6KGG|c3H5 M3\YUVczKGi{cx?= MY\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDLOVYzKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDYWHQh[XO|YYmsJGdKPTBiPTCwMlAxPzRizszNMi=> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODV7MU[3PEc,OjB3OUG2O|g9N2F-
NCI-H460 NGfYPYREgXSxdH;4bYNqfHliYYPzZZk> M3X0PFczKGi{cx?= NEfOeGJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBPS0lvSES2NEBk\WyuczDh[pRmeiB5MjDodpMh[nliWGTUJIF{e2G7LDDHTVUxKD1iMD6zPEDPxE1w NGrYVZk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEW5NVY4QCd-MkC1PVE3Pzh:L3G+
SF268 MnnYR5l1d3SxeHnjbZR6KGG|c3H5 MXi3NkBpenN? M1;GNWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHNHOjZ6IHPlcIx{KGGodHXyJFczKGi{czDifUBZXFRiYYPzZZktKEeLNUCgQUAxNjZizszNMi=> NILpdVk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEW5NVY4QCd-MkC1PVE3Pzh:L3G+
MCF7 MmjER5l1d3SxeHnjbZR6KGG|c3H5 MYq3NkBpenN? NX3sWVNpS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA4OiCqcoOgZpkhYFSWIHHzd4F6NCCJSUWwJF0hOC56NjFOwG0v NH3CZVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEW5NVY4QCd-MkC1PVE3Pzh:L3G+
Detroit 551 MUXDfZRwfG:6aXPpeJkh[XO|YYm= MYi3NkBpenN? MmrWR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gSIV1em:rdDC1OVEh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IGjUWEBie3OjeTygS2k2OCB;IEGuO|ch|ryPLh?= NX3FOFU2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkC1PVE3PzhpPkKwOVkyPjd6PD;hQi=>
HL60 Mn7QR5l1d3SxeHnjbZR6KGG|c3H5 M3zMRlQ5KGi{cx?= M4HOWWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhNPjBiY3XscJMh[XO|ZYPz[YQh[XNiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhPDhiaILzJIJ6KHS{eYDhckBjdHWnIIP0ZYlvcW6pLXLhd4VlKGinbX;jfZRwdWW2cnnjJIFv[Wy7c3nzMEBIUTVyIE2gNE4yKM7:TT6= M3\0U|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe0N|M2Lz5{NUi3OFM{PTxxYU6=
HL60R MkfWR5l1d3SxeHnjbZR6KGG|c3H5 NH35UXY1QCCqcoO= MknOR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTGw3OFJiY3XscJMh\XiycnXzd4lv\yCyLXfsfYNweHKxdHXpckBie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhfHK7cHHuJIJtfWVic4ThbY5qdmdvYnHz[YQhcGWvb3P5eI9u\XS{aXOgZY5idHm|aYOsJGdKPTBiPTCzPEDPxE1w NV76VJMxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|Q{OzVpPkK1PFc1OzN3PD;hQi=>
P388 NV7qXWM4SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NU\qUIg3PDhiaILz NEXFUpJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JI1wfXOnIGCzPFgh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNFI5KM7:TT6= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzd6NES5K|4zPzd6NES5QE9iRg>?
HT-29 Mn3nRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NGT4SHo6PiCqcoO= NISxbHBCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjUMVI6KGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlE{OyEQvF2u NHrVVXM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{e4OFQ6Lz5{N{e4OFQ6RC:jPh?=
HeLa MkLSSpVv[3Srb36gZZN{[Xl? NGK1Rm5VWF:WUlHOV3BQWlSHUkqgbY5pcWKrdHnvckBw\iCHMkG3ZoV1[UdidYD0ZYtmKCiHMkG3ZoV1[Ud8IECuNFUhfU1rIHnuJI1mdWK{YX7lJJZme2mlbHWg[pJwdSCPUmCxMYV5eHKnc4PpcochUGWOYTDj[YxteyxiSVO1NEA:KDhizszNMi=> MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek85PjJzNkS0K|45PjJzNkS0QE9iRg>?
breast carcinoma line cells NYfRdnBuTnWwY4Tpc44h[XO|YYm= NEnsNZhkd22yb4Xu[EB4[XNidHXzeIVlKGmwII\peJJwKG[xcjDpcohq[mm2aX;uJIFkfGm4aYT5JIFo[Wmwc4SgZUB{\W6|aYTpeoUhcHWvYX6gZpJm[XO2IHPhdoNqdm:vYTDsbY5mKGOnbHzzMEBKSzVyIE2gNE4xPiEQvF2u NIm5V3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi97MkW4N|UyLz57MkW4N|UyRC:jPh?=
breast carcinoma line cells NWPybXhQTnWwY4Tpc44h[XO|YYm= M33kNYNwdXCxdX7kJJdieyC2ZYP0[YQhcW5idnn0do8h\m:{IHnubIljcXSrb36gZYN1cX[rdImgZYdicW6|dDDkc5hwenWkaXPpckBz\XOrc4ThcpQh[2:3boTldpBienRib3[gbJVu[W5iYoLlZZN1KGOjcnPpco9u[SCuaX7lJINmdGy|LDDJR|UxKD1iMjFOwG0v M2LENVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493Nzl{NUizOVEoRjl{NUizOVE9N2F-
MCF-7 NXXPOVRzTnWwY4Tpc44h[XO|YYm= Mme1R49ueG:3bnSge4F{KHSnc4Tl[EBnd3JiaYTzJJRwgGmlaYT5JIFo[Wmwc4SgbJVu[W5iYoLlZZN1KGOjbnPldkBk\WyuczjNR2YuPyluIFnDOVAhRSByLkC2JO69VS5? MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek86PTR6OEKwK|46PTR6OEKwQE9iRg>?
MCF-7/ADR NVvlXpBWTnWwY4Tpc44h[XO|YYm= MlS3R49ueG:3bnSge4F{KHSnc4Tl[EBnd3JiaYTzJJRwgGmlaYT5JIFo[Wmwc4Sg[I95d3K3YnnjbY4hemW|aYP0ZY51KGi3bXHuJIJz\WG|dDDjZY5k\XJiY3XscJMhME2FRj23M2FFWiluIFnDOVAhRSB{IN88UU4> M2OyT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493Nzl3NEi4NlAoRjl3NEi4NlA9N2F-
L1210 NV61eW1FTnWwY4Tpc44h[XO|YYm= NGTHZ|VKdmirYnn0c5J6KGGldHn2bZR6KHejczDt[YF{fXKnZDDh[4FqdnO2IH31dolv\SCOMUKxNEBt\XWtZX3pZUBk\WyuczygTWM2OCB;IECuNFMh|ryPLh?= NWriTIdJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxOUezN|Q5Oyd-OUezN|Q5OzxxYU6=
HL60 M4XUbmZ2dmO2aX;uJIF{e2G7 MmHwTY4hfmm2cn:gbY5pcWKrdH;yfUBkd26lZX70doF1cW:wIHHnZYlve3RicILvcIln\XKjdHnvckBw\iCKTE[wJINmdGy|LDDJR|UxKD1iMD6wNFUh|ryPLh?= NUHJXFJZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK4O|c2QTNpPkGyPFc4PTl|PD;hQi=>
HL60R NX\OXI1xTnWwY4Tpc44h[XO|YYm= NEjUcYlKdiC4aYTyc{BqdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gZYdicW6|dDDwdo9tcW[ncnH0bY9vKG:oIFjMOlBTKGOnbHzzJIFtd26pIIfpeIghPSBqdV2pJJZmemGyYX3pcEwhUUN3MDC9JFAvODRizszNMi=> MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOjh5N{W5N{c,OTJ6N{e1PVM9N2F-
HL60R NWTGNFgyTnWwY4Tpc44h[XO|YYm= M4fUOmlvKH[rdILvJIlvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IIDyc4xq\mW{YYTpc44hd2ZiSFy2NHIh[2WubIOsJGlEPTBiPTCxMlUh|ryPLh?= M{S1UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF{OEe3OVk{Lz5zMki3O|U6OzxxYU6=
K562 MXXDfZRwfG:6aXPpeJkh[XO|YYm= M{frcGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KEt3NkKgZ4VtdHNiYomgUXRUNCCLQ{WwJF0hOC5yMUWg{txONg>? M176OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4NEWxNFU6Lz5zNkS1NVA2QTxxYU6=
P388 MWrBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NHXrZnRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JHA{QDhiY3XscJMh[nliRVzJV2EtKEmFNUCgQUAxNjB{NTFOwG0v MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF3NEWwOUc,OTdzNUS1NFU9N2F-
P388 MYHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M17ZfmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgZYRzcWGveXPpckBz\XOrc4ThcpQhWDN6ODDj[YxteyCrbjDwdoV{\W6lZTDv[kA2KHWPII\ldoFx[W2rbDDifUBGVEmVQTygTWM2OCB;IECuNFQh|ryPLh?= MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF3NEWwOUc,OTdzNUS1NFU9N2F-
MDA435/LCC6 MWfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NXLXUGtlSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBOTEF2M{WvUGNEPiClZXzsd{BjgSCHTFnTRUwhUUN3MDC9JFAvODd7IN88UU4> NVi5UFNjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUexOVQ2ODVpPkG3NVU1PTB3PD;hQi=>
P388 NXf3SJQ5SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NUHSSWZ2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBi\HKrYX35Z4lvKHKnc3nzeIFvfCCSM{i4JINmdGy|IHnuJJBz\XOnbnPlJI9nKDVidV2gNUwyOy2kaYPbOEcuMCh3LEet[IlpgWS{b4j5LU01UC2laILvcYVvNTRvb36tNk16dCmyaHXufYxeNTFuNDy3MFExNDF|LYDlcpRid3ijdILp[IVk[W6nIHL5JGVNUVODLDDJR|UxKD1iMD6xNFYh|ryPLh?= MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF3NEWwOUc,OTdzNUS1NFU9N2F-
MDA435/LCC6 MYfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NEniOlNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JI12dHSrZIL1[{Bz\XOrc4ThcpQhVUSDNEO1M2xESzZiY3XscJMhcW5icILld4Vv[2Vib3[gOUB2VSBzLEGzMYJqe1t2Jz2oLFUtPy2maXj5[JJwgHlrLUTIMYNpem:vZX6tOE1wdi1{LYnsLZBp\W67bG2tNUw1NDduMUCsNVMueGWwdHHvfIF1emmmZXPhcoUh[nliRVzJV2EtKEmFNUCgQUAxNjF{OTFOwG0v MnG4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTdzNUS1NFUoRjF5MUW0OVA2RC:jPh?=
MDA435/LCC6 NH[yUVNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M2\Z[mFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcZVtfGmmcoXnJJJme2m|dHHueEBOTEF2M{WvUGNEPiClZXzsd{BjgSCHTFnTRUwhUUN3MDC9JFAvQTd5IN88UU4> M2HNeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MUW0OVA2Lz5zN{G1OFUxPTxxYU6=
P388 MVfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NWSwZlVWSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBi\HKrYX35Z4lvKHKnc3nzeIFvfCCSM{i4JINmdGy|IHL5JGVNUVODLDDJR|UxKD1iMj6xNVEh|ryPLh?= MlX1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTdzNUS1NFUoRjF5MUW0OVA2RC:jPh?=
A2780 MXPDfZRwfG:6aXPpeJkh[XO|YYm= NXnPPHZbPzJiaILz NUP3fWJpS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTJ5OECgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMUG3OFkh|ryPLh?= MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzh7MEC5OEc,OTd6OUCwPVQ9N2F-
A2780/ADR M{HoPGN6fG:2b4jpZ4l1gSCjc4PhfS=> MmnsO|IhcHK| MlPKR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVI4QDBxQVTSJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzOD62NlA6KM7:TT6= NYLxNoJ4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe4PVAxQTRpPkG3PFkxODl2PD;hQi=>
NIH/3T3 M4HxOGN6fG:2b4jpZ4l1gSCjc4PhfS=> NV7OVWNPPzJiaILz MULJcpRzcW6|aXOgZ5l1d3SxeHnjbZR6KGGpYXnud5Qhf2muZDD0fZBmKG2xdYPlJG5KUC9|VEOgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMES0JO69VS5? MmntQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh7NUSwOFAoRjF6OUW0NFQxRC:jPh?=
NIH/3T3 NECyRpBEgXSxdH;4bYNqfHliYYPzZZk> NHflSFc4OiCqcoO= NV3DNoFrUW62cnnud4lkKGO7dH;0c5hq[2m2eTDh[4FqdnO2IH3veZNmKE6LSD:zWFMh[2WubIOgc5ZmemW6cILld5NqdmdiTVTSNUBi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNU4xOSEQvF2u M2CyZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6OUW0NFQxLz5zOEm1OFA1ODxxYU6=
KB MV;DfZRwfG:6aXPpeJkh[XO|YYm= MXy0PEBpenN? NVfQUJZbS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hU0JiY3XscJMh[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvPjRizszNMi=> MlTNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB|NkOxOFIoRjJyM{[zNVQzRC:jPh?=
KB-C2 M17hTmN6fG:2b4jpZ4l1gSCjc4PhfS=> NES1W4k1QCCqcoO= MWjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDteYx1cWS{dXetdoV{cXO2YX70JGtDNUN{IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyPi5{IN88UU4> M{fROlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{[zNVQzLz5{MEO2N|E1OjxxYU6=
HT-29 M1H6ZmN6fG:2b4jpZ4l1gSCjc4PhfS=> NIHNeXkzPCCqcoO= NIT6dnJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJXC1{OTDj[YxteyCjZoTldkAzPCCqcoOgZpkhVVSVIHHzd4F6NCCLQ{WwJF0hOC52IN88UU4> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB7NEC0PUc,OjFyOUSwOFk9N2F-
HepG2 MWfDfZRwfG:6aXPpeJkh[XO|YYm= MkLXNlQhcHK| NWjmOJRJS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjRiaILzJIJ6KE2WUzDhd5NigSxiSVO1NEA:KDBwNzFOwG0v M1Tn[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEm0NFQ6Lz5{MUC5OFA1QTxxYU6=
NIH/3T3 NVz0SIFHS3m2b4TvfIlkcXS7IHHzd4F6 NEi1Om4{KGSjeYO= NYK5O3BUS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVkmKL{PUN{Bk\WyuczDh[pRmeiB|IHThfZMh[nliTWTTJIF{e2G7LDDJR|UxKD1iMT64JO69VS5? MnmwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOUSwOFkoRjJzMEm0NFQ6RC:jPh?=
Vero NVPxTJZ5S3m2b4TvfIlkcXS7IHHzd4F6 NYLkS3VnOyCmYYnz NWLYcmNoS3m2b4TvfIlkcXS7IHHnZYlve3RiYX\ybYNidiCpcnXlckBud26tZYmgWoVzdyClZXzsd{Bi\nSncjCzJIRigXNiYomgUXRUKGG|c3H5MEBKSzVyIE2gNk42KM7:TT6= M1PlN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEm0NFQ6Lz5{MUC5OFA1QTxxYU6=
MCF7 NYjJXGgxS3m2b4TvfIlkcXS7IHHzd4F6 M4XDR|I1KGi{cx?= NIPCPYFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFI1KGi{czDifUBOXFNiYYPzZZktKEmFNUCgQUA2NjVizszNMi=> M3r5e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEm0NFQ6Lz5{MUC5OFA1QTxxYU6=
CRL7761 NX7uS3FqS3m2b4TvfIlkcXS7IHHzd4F6 M1;sV|Mh\GG7cx?= NVLOZYE2S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hS1KON{e2NUBk\WyuczDh[pRmeiB|IHThfZMh[nliTWTTJIF{e2G7LDDJR|UxKD1iMUCuOUDPxE1w NXvqUmE3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGwPVQxPDlpPkKxNFk1ODR7PD;hQi=>
NCI-H460 NFf5VHVCdnSrY3HuZ4VzKGG|c3H5 NF3Xe3FCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh2NkCgZ4VtdHNuIFnDOVAhRSByLkO4JO69VS5? MlLRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF3OUmwNFAoRjJzNUm5NFAxRC:jPh?=
SF268 NYGy[WZ7SW62aXPhcoNmeiCjc4PhfS=> NV;4OVViSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNHOjZ6IHPlcIx{NCCLQ{WwJF0hOC54IN88UU4> MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTV7OUCwNEc,OjF3OUmwNFA9N2F-
MRC5 M3j0dWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MmXhRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPUlO1JINmdGy|LDDJR|UxKD1iMD64PEDPxE1w NULmboh3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG1PVkxODBpPkKxOVk6ODByPD;hQi=>
MCF7 NHzpUoJCdnSrY3HuZ4VzKGG|c3H5 MoiyRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOsJGlEPTBiPTC1MlA{KM7:TT6= Mlj3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF3OUmwNFAoRjJzNUm5NFAxRC:jPh?=
DU145 M3vITWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M3GxZVczKGi{cx?= MYrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKESXMUS1JINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGOgZZN{[XluIFnDOVAhRSByLkC5JO69VS5? NWXTPVNERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyOlAyPjZpPkKyNlYxOTZ4PD;hQi=>
SKMES1 NGHDcYRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MWq3NkBpenN? M4jDfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1vNSXMyKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHMh[XO|YYmsJGlEPTBiPTCwMlE4KM7:TT6= NYPDSWRXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyOlAyPjZpPkKyNlYxOTZ4PD;hQi=>
MCF7 NH:0Tm9CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MnjJO|IhcHK| MUDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WUzDhd5NigSxiSVO1NEA:KDBwOUWg{txONg>? Mlv6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{NkCxOlYoRjJ{Mk[wNVY3RC:jPh?=
LNCAP NIW0flNEgXSxc4TheIlkKGG|c3H5 MX[0JIRigXN? MmrSR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFzOR2FRKGOnbHzzJIFnfGW{IESg[IF6eyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlEh|ryPLh?= M4D4d|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NEiwOFk2Lz5{MkS4NFQ6PTxxYU6=
HT-29 M{nPSmN6fG:|dHH0bYMh[XO|YYm= NUWyPFhTPCCmYYnz M4roUmN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWE0zQSClZXzsd{Bi\nSncjC0JIRigXNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE4zKM7:TT6= NInYO289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4NFQ6PSd-MkK0PFA1QTV:L3G+
MCF7 NY\RTW9RS3m2b4P0ZZRq[yCjc4PhfS=> Mn\OOEBl[Xm| MmP3R5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNDDkZZl{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuOEDPxE1w MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjR6MES5OUc,OjJ2OEC0PVU9N2F-
HepG2 M{iwXGZ2dmO2aX;uJIF{e2G7 NVzZfY8xUEGUVlHSSFohUW6qaXLpeIlwdiCxZjDsbZZmeiC|dHHn[UBRdGG|bX;kbZVuKGKncnfo[YkhcW6oZXP0bY9vKGmwIFjldGczKGOnbHzzMEBKSzVyIE2gNk46QSEQvF2u NV\pWmExRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1PFYyOjRpPkKyOVg3OTJ2PD;hQi=>
THP1 NHzycWtEgXSxdH;4bYNqfHliYYPzZZk> NWTzW|NCPzJiaILz MXXDfZRwfG:6aXPpeJkh[WejaX7zeEBRVUFvc4TpcZVt[XSnZDDoeY1idiCWSGCxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB{Nj65JO69VS5? MmiwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7M{m2PVUoRjJ{OUO5Olk2RC:jPh?=
L5178Y MmizR5l1d3SxeHnjbZR6KGG|c3H5 NGi2TlEzPCCqcoO= NXLOe|JpS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVDVzN{jZJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkOg{txONg>? NETWV3g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{G5PVQ4QSd-MkOxPVk1Pzl:L3G+
L5178Y M2r0[2N6fG:2b4jpZ4l1gSCjc4PhfS=> MXqyOEBpenN? MV\DfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDMOVE4QFliY3XscJMh[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvPzNizszNMi=> MnTpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzOUm0O|koRjJ|MUm5OFc6RC:jPh?=
L5178Y NF:zd3BEgXSxdH;4bYNqfHliYYPzZZk> MXuyOEBpenN? M3zp[WN6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJGw2OTd6WTDj[YxteyCneIDy[ZN{cW6pIICt[5Ah[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFIvOzJizszNMi=> MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF7OUS3PUc,OjNzOUm0O|k9N2F-
L5178Y M4HwOmN6fG:2b4jpZ4l1gSCjc4PhfS=> MWWyOEBpenN? MV;DfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDMOVE4QFliY3XscJMh\XiycnXzd4lv\yCyLXfwJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTC3Mlc{KM7:TT6= NHW3Uo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{G5PVQ4QSd-MkOxPVk1Pzl:L3G+
DA-3 Mm[3R5l1d3SxeHnjbZR6KGG|c3H5 MkjyNlQhcHK| MVvDfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDERU0{KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDYWHQh[XO|YYmsJGlEPTBiPTCxMlkh|ryPLh?= MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyME[2PEc,OjR7MEC2Olg9N2F-
SKOV3 MmPsR5l1d3SxeHnjbZR6KGG|c3H5 MnWyNlQhcHK| MknaR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2tQXjNiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JHhVXCCjc4PhfUwhUUN3MDC9JFIxNjZizszNMi=> MmT4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MEC2OlgoRjJ2OUCwOlY5RC:jPh?=
ES2 M4L5[WN6fG:2b4jpZ4l1gSCjc4PhfS=> MV6yOEBpenN? NUTHXmV5S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hTVN{IHPlcIx{KGGodHXyJFI1KGi{czDifUBZXFRiYYPzZZktKEmFNUCgQUAzPS53IN88UU4> NHPB[2Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFY3QCd-MkS5NFA3Pjh:L3G+
MCF7 NGPLTYhEgXSxdH;4bYNqfHliYYPzZZk> NHmz[mIzPCCqcoO= MnzxR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjCyOEBpenNiYomgXHRVKGG|c3H5MEBKSzVyIE2gN|MvQSEQvF2u M{fzNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwOlY5Lz5{NEmwNFY3QDxxYU6=
MRC5 MX7BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MkjmRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPUlO1JINmdGy|IHL5JHhVXCCjc4PhfUwhUUN3MDC9JFAvODd6IN88UU4> MlrCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2NkeyPVEoRjJ3NE[3NlkyRC:jPh?=
A549 NH3RNnZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= Mnj0RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDNUS5JINmdGy|IHL5JHhVXCCjc4PhfUwhUUN3MDC9JFAvODhizszNMi=> NYLKc3N7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0OlczQTFpPkK1OFY4OjlzPD;hQi=>
MDA-MB-231 MoPJRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NF3pSm5CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYomgXHRVKGG|c3H5MEBKSzVyIE2gNE4xQTFizszNMi=> MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR4N{K5NUc,OjV2NkeyPVE9N2F-
H1299 Mo\URY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MoLKRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKMUK5PUBk\WyuczDifUBZXFRiYYPzZZktKEmFNUCgQUAxNjB7NjFOwG0v M{TMSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NE[3NlkyLz5{NUS2O|I6OTxxYU6=
MCF7 Ml7IRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NGrRcoNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZpkhYFSWIHHzd4F6NCCLQ{WwJF0hOC54NTFOwG0v M{[1S|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NE[3NlkyLz5{NUS2O|I6OTxxYU6=
HEK293 NIW5Z5lEgXSxdH;4bYNqfHliYYPzZZk> MV6yOEBpenN? NXfDdpBVS3m2b4TvfIlkcXS7IHHnZYlve3RiSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGOnbHygeoli[mmuaYT5JIFnfGW{IEK0JIhzeyCkeTDBcIFu[XJiQnz1[UBie3OjeTygTWM2OCB;IEGyMlU2KM7:TT6= NVrzT3BPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[5N|c5OjhpPkK2PVM4QDJ6PD;hQi=>
MCF7/ADR NX\NSIlsT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NHL4Now1QCCqcoO= MofOS5Jwf3SqIHnubIljcXSrb36gc4YhcHWvYX6gUWNHPy:DRGKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KFOUQjDhd5NigSxiSVO1NEA:KDdwMUKg{txONg>? MonyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NE[wOFEoRjJ6MkS2NFQyRC:jPh?=
HCT16 M4DaUGN6fG:2b4jpZ4l1gSCjc4PhfS=> M1GwRlczKGi{cx?= Mon4R5l1d3SxeHnjbZR6KGmwIHj1cYFvKEiFVEG2JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBoem:5dHigbY5kfWKjdHXkJIZweiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMD6yNUDPxE1w MmnpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7MkOzPFIoRjJ6OUKzN|gzRC:jPh?=
A549 NVP5U21jS3m2b4TvfIlkcXS7IHHzd4F6 M1HTbFczKGi{cx?= NGP5c|lEgXSxdH;4bYNqfHliaX6gbJVu[W5iQUW0PUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPlcIwh\3Kxd4ToJIlv[3WkYYTl[EBnd3JiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuOVEh|ryPLh?= NHXGeHM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEmyN|M5Oid-Mki5NlM{QDJ:L3G+
MCF7 NE\4fGhEgXSxdH;4bYNqfHliYYPzZZk> MYq3NkBpenN? M2e1emN6fG:2b4jpZ4l1gSCrbjDoeY1idiCPQ1[3JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3XscEBoem:5dHigbY5kfWKjdHXkJIZweiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMT60OEDPxE1w M3PnSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUKzN|gzLz5{OEmyN|M5OjxxYU6=
RD Mli1R5l1d3SxeHnjbZR6KGG|c3H5 MUK3NkBpenN? M2\ob2N6fG:2b4jpZ4l1gSCrbjDoeY1idiCURDDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHyg[5Jwf3SqIHnuZ5Vj[XSnZDDmc5IhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDJwNEWg{txONg>? M4DXUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUKzN|gzLz5{OEmyN|M5OjxxYU6=
HEK293 NHnjWVFEgXSxdH;4bYNqfHliYYPzZZk> NGC5TGk4OiCqcoO= MlzHR5l1d3SxeHnjbZR6KGmwIHj1cYFvKEiHS{K5N{Bk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPlcIwh\3Kxd4ToJIlv[3WkYYTl[EBnd3JiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGxMlE4KM7:TT6= NHjE[JU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEmyN|M5Oid-Mki5NlM{QDJ:L3G+
CCRF-CEM MnHzS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MXrJckB3cXS{bzDndo94fGhiaX7obYJqfG:{eTDhZ5Rqfmm2eTDh[4FqdnO2IFPDVmYuS0WPIDjoeY1idiCueX3wbI9jdGG|dHnjJIxmfWunbXnjLUBk\WyuczygTWQ2OCB;IECuNFQh|ryPLh?= NGPDcVI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi94OUWxNFQ6Lz54OUWxNFQ6RC:jPh?=
CCRF-CEM M4TpWmZ2dmO2aX;uJIF{e2G7 MknzTY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JGNEWkZvQ1XNLIh2dWGwIHzleYtmdWmlIHz5cZBpd2KuYYP0bYMqKGOnbHzzJIlvKGO3bIT1doUtKEmGNUCgQUAxNjB2IN88UU4> NHnrXXU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi95MEW3OFI3Lz55MEW3OFI3RC:jPh?=
Sf9 NUjkdGl2TnWwY4Tpc44h[XO|YYm= NUDaSZpEXFChVGLBUnNRV1KWRWK6JGFVWCCqeXTyc4x6e2m|IHnuJI1mdWK{YX7lJJZme2mlbHWg[pJwdSCEQ2LQMYV5eHKnc4PpcochW2Z7IHPlcIx{NCCNYXP0JF0hOi53IN88UU4> MkHMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF2M{ezPFAoRjFzNEO3N|gxRC:jPh?=
GLC4/ADR M3XOc2Z2dmO2aX;uJIF{e2G7 NGG0[21VWF:WUlHOV3BQWlSHUkqgbY5pcWKrdHnvckBw\iCGTmCtV2chfXC2YXvlJIlvKG2nbXLyZY5mKH[nc3njcIV{KG[{b32gS2xEPC:DRGKgZ4VtdHNuIFvpJF0hOC57NTFOwG0v M3LoSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzlzOEi3PVYoRjlzOEi3PVY9N2F-
SR3A NX\4[HpYTnWwY4Tpc44h[XO|YYm= MUnUVH9VWkGQU2DPVnRGWjpiaX7obYJqfGmxbjDv[kBNXEN2IIXweIFs\SCrbjDt[Y1jemGwZTD2[ZNq[2ynczDmdo9uKFOUM1GgZ4VtdHNuIFvpJF0hOC5yNzFOwG0v MkXoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwQTZ2N{e4N{c,QTZ2N{e4N|ww[T5?
Caco-2 NIPkcVlHfW6ldHnvckBie3OjeR?= MV\UVH9VWkGQU2DPVnRGWjpiaX7obYJqfGmxbjDv[kBV[XixbDD0doFve2WyaYTo[Yxq[WxidILhcpNxd3K2IDjiZZNidCC2bzDhdIlk[WxrIHnuJGNi[29vMjDj[YxteyxiS3mgQUAzNjVizszNMi=> M{\IVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzNEC1Nlg4Lz5zMUSwOVI5PzxxYU6=
MDCK MV3GeY5kfGmxbjDhd5NigQ>? MX7UVH9VWkGQU2DPVnRGWjpiaX7obYJqfGmxbjDv[kBXcW6kbHHzeIlv\SC2cnHud4VxcXSqZXzpZYwhfHKjboPwc5J1KCikYYPhcEB1dyCjcHnjZYwqKGmwIF3SVFIu\XiycnXzd4lv\yCPRFPLJINmdGy|LDDLbUA:KDR7LkSg{txONg>? NUjmWoV7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUKxN|Q6PDZpPkGyNVM1QTR4PD;hQi=>
GLC4/ADR NFTNWYVHfW6ldHnvckBie3OjeR?= M3vsNnRRZ1SUQV7TVG9TXEWUOjDl[oZtfXhiaX6gS2xEPC:DRGKgZ4VtdHNuIFvtJF0hOS52IN88UU4> NWntSItzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxN{m0OVQxPid-N{m0OVQxPjxxYU6=
BTI-TN5B1-4 NYPBR5NMTnWwY4Tpc44h[XO|YYm= NHW3TmRVWF:WUlHOV3BQWlSHUkqgRXRRKGi7ZILvcJl{cXNiaX6gcYVu[nKjbnWg[pJi[3Srb36g[pJwdSCKaXfoJGZqfmViKFLUTU1VVjWEMT20LUBk\WyuczygT40hRSBzLke0JO69VS5? NF[3dVE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUe4OVY5PCd-MUG3PFU3QDR:L3G+
A549 NWrXPFlGS3m2b4TvfIlkcXS7IHHzd4F6 MnTVO|IhcHK| MlXVR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiTFO1NEA:KDBwM{Wg{txONg>? M1H4OlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OU[4NlU5Lz5zOUm2PFI2QDxxYU6=
MDA-MB-231 NYfjXnViS3m2b4TvfIlkcXS7IHHzd4F6 NFfqVFk4OiCqcoO= NHS4OllEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCOQ{WwJF0hOC56NjFOwG0v MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTl4OEK1PEc,OTl7NkiyOVg9N2F-
CEM M1XLdmN6fG:2b4jpZ4l1gSCjc4PhfS=> MYe3NkBpenN? NVr6N5FIS3m2b4TvfIlkcXS7IHHnZYlve3RiQ1XNJINmdGy|IHHmeIVzKDd{IHjyd{whXEOVNUCgQUAxNjB4MjFOwG0v M2fnZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NkC4N|k3Lz5zN{[wPFM6PjxxYU6=
MCF7 MV;DfZRwfG:6aXPpeJkh[XO|YYm= MXK3NkBpenN? MlX1R5l1d3SxeHnjbZR6KGGpYXnud5QhVUOINzDj[YxteyCjZoTldkA4OiCqcoOsJHREWzVyIE2gNE4yPCEQvF2u MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzZyOEO5Okc,OTd4MEizPVY9N2F-
K562 NV3x[oUxS3m2b4TvfIlkcXS7IHHzd4F6 NVXSO3JDPzJiaILz MW\DfZRwfG:6aXPpeJkh[WejaX7zeEBMPTZ{IHPlcIx{KGGodHXyJFczKGi{czygWGNUPTBiPTCwMlI{KM7:TT6= MojNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd4MEizPVYoRjF5NkC4N|k3RC:jPh?=
HOS M3S3T2N6fG:2b4jpZ4l1gSCjc4PhfS=> MWS3NkBpenN? NFfqV2ZEgXSxdH;4bYNqfHliYXfhbY5{fCCKT2OgZ4VtdHNiYX\0[ZIhPzJiaILzMEBVS1N3MDC9JFAvOzNizszNMi=> NInFVVI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{[wPFM6Pid-MUe2NFg{QTZ:L3G+
G361 M3XObmN6fG:2b4jpZ4l1gSCjc4PhfS=> NXizZVJxPzJiaILz M2DyNWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGc{PjFiY3XscJMh[W[2ZYKgO|IhcHK|LDDUR3M2OCB;IECuOlch|ryPLh?= MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzZyOEO5Okc,OTd4MEizPVY9N2F-
HeLa NWXXR|V6S3m2b4TvfIlkcXS7IHHzd4F6 M3jne|czKGi{cx?= NHPPXZBEgXSxdH;4bYNqfHliYXfhbY5{fCCKZVzhJINmdGy|IHHmeIVzKDd{IHjyd{whXEOVNUCgQUAxNjZ5IN88UU4> NFvoWXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{[wPFM6Pid-MUe2NFg{QTZ:L3G+
MDA-MB-231 NGjjOoFEgXSxdH;4bYNqfHliYYPzZZk> NIf4ZW44OiCqcoO= M2G1NmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1FSS2PQj2yN|Eh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKFSJSTC9JFAvOTJizszNMi=> NX\pUXpyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm5OlgzPThpPkG5PVY5OjV6PD;hQi=>
A549 NIrwWllEgXSxdH;4bYNqfHliYYPzZZk> NYX5cXR3PzJiaILz MoSxR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiVFfJJF0hOC5zNzFOwG0v MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTl4OEK1PEc,OTl7NkiyOVg9N2F-
HT-29 NEPBcmVEgXSxdH;4bYNqfHliYYPzZZk> M3[4c|czKGi{cx?= MYXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIWE0zQSClZXzsd{Bi\nSncjC3NkBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiVFfJJF0hOC5|MzFOwG0v NI[5bZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUm2PFI2QCd-MUm5OlgzPTh:L3G+
K562 NEPwZnpHfW6ldHnvckBie3OjeR?= NYH2O2JYUW6lcnXhd4UhcW5idHjlJIxmfmWuIH;mJIRzfWdidYD0ZYtmKGmwIFTvfE1z\XOrc4ThcpQhUzV4MjDj[YxteyCrbjDwdoV{\W6lZTDv[kBkgWOub4Pwc5JqdmVib4\ldkBqfHNiYXLz[Y5k\Q>? NXnITIFTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[0OVExPTlpPkG2OFUyODV7PD;hQi=>
K562 MULGeY5kfGmxbjDhd5NigQ>? MXvJcoNz\WG|ZTDpckB1cGVibHX2[Ywhd2ZiZIL1[{Bm\m[udYigbY4hTG:6LYLld4l{fGGwdDDLOVYzKGOnbHzzJIlvKHC{ZYPlcoNmKG:oIHP5Z4xwe3Cxcnnu[UBwfmW{IHn0d{Bi[nOnbnPl NGfqTmg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNkS1NVA2QSd-MU[0OVExPTl:L3G+
KB MVfBdI9xfG:|aYOgZZN{[Xl? Ml7sNUB2VQ>? Ml3uNlQhcHK| MWTJcoR2[3Srb36gc4Yh[XCxcITveIlkKGGldHn2bZR6KGmwIHj1cYFvKEuEIHPlcIx{KGG2IEGgeW0h[W[2ZYKgNlQhcHK| MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDZ6MEK3OUc,OTh4OECyO|U9N2F-
DU145 M2TEPGZ2dmO2aX;uJIF{e2G7 NGSycZQ6OCCwTR?= M1r6N|czKGi{cx?= NXLXTFVQUW6qaXLpeIlwdiCxZjD0c5BwcXOxbXXyZZNmKDJiaX6gbJVu[W5iRGWxOFUh[2WubIOgZZN{\XO|ZXSgZZMhe3SjYnnsbZpifGmxbjDv[kBmdnq7bXWtSG5CKGOuZXH2ZYdmKGOxbYDs[Zgh[XRiOUCgcm0h[W[2ZYKgO|IhcHK|IHL5JIludXWwb3Lsc5Qh[W6jbInzbZM> MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ4MEG2Okc,OjJ{NkCxOlY9N2F-
DU145 MlnpSpVv[3Srb36gZZN{[Xl? NXvTbIJMQTBibl2= NVHKeopFOzBibXnudy=> M2[1e2lvcGmkaYTpc44hd2ZidH;wc4l{d22ncnHz[UAzKGmwIHj1cYFvKESXMUS1JINmdGy|IHHzd4V{e2WmIHHzJJN1[WKrbHn6ZZRqd25ib3[g[Y57gW2nLVTORUBkdGWjdnHn[UBkd22ybHX4JIF1KDlyIH7NJIFnfGW{IEOwJI1qdnNiYomgbY1ufW6xYnzveEBidmGueYPpdy=> M{\jRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mk[wNVY3Lz5{MkK2NFE3PjxxYU6=
DU145 NVTUd|FrTnWwY4Tpc44h[XO|YYm= MYi1NFAhdk1? MnmwOEBpenN? NV3Jd3FoUW6qaXLpeIlwdiCxZjDISGFEPi2vZXTpZZRm\CC2dXL1cIlvKGGlZYT5cIF1cW:wIHnuJIh2dWGwIFTVNVQ2KGOnbHzzJIF1KDVyMDDuUUBi\nSncjC0JIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> NX;qWIZTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyOlAyPjZpPkKyNlYxOTZ4PD;hQi=>
DU145 NWHGPGhZTnWwY4Tpc44h[XO|YYm= MmHHNE4yKHSxIECuOUB2VQ>? MYeyOEBpenN? NFXuNIJKdmirYnn0bY9vKG:oIFjERWMhcW5iaIXtZY4hTFVzNEWgZ4VtdHNiYYPz[ZN{\WRiYYOgbIl{fG:wZTDIN{BpgXCncnHj[ZR6dGG2aX;uJIF1KDBwMTD0c{AxNjVidV2gZYZ1\XJiMkSgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ4MEG2Okc,OjJ{NkCxOlY9N2F-
DA-3 NFW3SJJEgXSxdH;4bYNqfHliYYPzZZk> NEXpOVYzOCC3TR?= NGPufHI3OCCvaX7z MUnDfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDERU0{KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjdDCyNEB2VSCjZoTldkA3OCCvaX7zJIJ6KFiWVDDhd5NigQ>? NG[3W3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFY3QCd-MkS5NFA3Pjh:L3G+
TC32 NEfTeYJyUFSVIHHzd4F6 MkH0dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFSFM{KgZ4VtdHN? NETHeYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
DAOY MX;xTHRUKGG|c3H5 M4jDR5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCGQV;ZJINmdGy| MofpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
A673 NUD6XHdHeUiWUzDhd5NigQ>? MlfldWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC MmL6dWhVWyCjc4PhfS=> NUPTVnNleUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NVnVO3NURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 MX;xTHRUKGG|c3H5 NIjaU2pyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStN|ch[2WubIO= M1KwblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
NB-EBc1 MlK1dWhVWyCjc4PhfS=> M1TmfZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQj3FRoMyKGOnbHzz M{\pcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
U-2 OS NHrMU2lyUFSVIHHzd4F6 MnzkdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFVvMjDPV{Bk\Wyucx?= NEXKR4g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Saos-2 NY\p[XN7eUiWUzDhd5NigQ>? MnHDdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOjb4OtNkBk\Wyucx?= MlG0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-SH NFrlW2xyUFSVIHHzd4F6 NGTyU|dyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1UUCClZXzsdy=> NGLKdmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB1643 MnradWhVWyCjc4PhfS=> M3vXdpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQkG2OFMh[2WubIO= MlzOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
BT-12 NWrVSnJ1eUiWUzDhd5NigQ>? M2C5fJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCEVD2xNkBk\Wyucx?= MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Rh18 Ml3KdWhVWyCjc4PhfS=> MXrxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>? NETOe4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
OHS-50 NYCz[Xo3eUiWUzDhd5NigQ>? NWPJV2w2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF;IV{02OCClZXzsdy=> M3Xhc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD MV\xTHRUKGG|c3H5 M4DiXZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCURDDj[Yxtew>? NF;odYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) MYTxTHRUKGG|c3H5 NGrxTpdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTVegOlMhMDZvVFegVkkh[2WubIO= M{jZTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
fibroblast cells MXzxTHRUKGG|c3H5 MWTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5Ih[2:wdILvcEBJcCC5aXzkJJR6eGViZnnido9jdGG|dDDj[Yxtew>? NHrFT2c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Rh41 NYHJbnY6eUiWUzDhd5NigQ>? NXvTSJBQeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLoOFEh[2WubIO= MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
P388 MlnyRY51cXS3bX;yJIF{e2G7 M2n6dlAvOjVidH:gNVAhdWdxa3e= NGTTTHBCdnSrdIXtc5Ih[WO2aY\peJkh[WejaX7zeEBud3W|ZTDQN|g5KGOnbHzzJIFtdG:pcnHmeIVlKGmwIH3veZNmKGG|c3Xzd4VlKGG|IIT1cY9zKGe{b4f0bEBqdmirYnn0bY9vKGG2IECuNlUhfG9iMUCgcYcwc2d? Mm\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTJ3NU[2NUc,OTJ3NU[2NVww[T5?
Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot p-Chk1 / Chk1 / p-ATR / ATR 26727128
Immunofluorescence p-Chk1 26727128
Growth inhibition assay Cell viability 30745844

Protocol (from reference)

Solubility (25°C)

In vitro

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
Saline
For best results, use promptly after mixing.

 30 mg/mL

Chemical Information

Molecular Weight 563.98
Formula

C27H29NO10 . HCl
CAS No. 23541-50-6
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04562792 Recruiting Drug: Daunorubicin Relapsed Pediatric ALL|Relapsed Pediatric AML|Refractory Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia Children''s Mercy Hospital Kansas City May 8 2020 Phase 2
NCT03878927 Recruiting Drug: CPX-351|Drug: Gemtuzumab Ozogamicin Acute Myeloid Leukemia Weill Medical College of Cornell University|Jazz Pharmaceuticals|Pfizer August 23 2019 Phase 1
NCT03896269 Recruiting Drug: Liposome-encapsulated Daunorubicin-Cytarabine Blasts 10-19 Percent of Bone Marrow Nucleated Cells|Blasts More Than 5 Percent of Bone Marrow Nucleated Cells|High Risk Chronic Myelomonocytic Leukemia|Recurrent Chronic Myelomonocytic Leukemia|Recurrent High Risk Myelodysplastic Syndrome|Refractory Chronic Myelomonocytic Leukemia|Refractory High Risk Myelodysplastic Syndrome M.D. Anderson Cancer Center|National Cancer Institute (NCI) May 14 2019 Phase 1

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Daunorubicin (RP 13057) HCl | Daunorubicin (RP 13057) HCl supplier | purchase Daunorubicin (RP 13057) HCl | Daunorubicin (RP 13057) HCl cost | Daunorubicin (RP 13057) HCl manufacturer | order Daunorubicin (RP 13057) HCl | Daunorubicin (RP 13057) HCl distributor